Research in these areas would be of great value, as angiopoietin- or Tie2-targeted therapies have been evaluated as alternative treatment strategies for severe sepsis [55, 56], severe dengue [57], and in cerebral malaria [39] infection models to restore endothelial quiescence during infection. This evidence concerns the gene TEK and cerebral malaria.